A necessary breakthrough !!!!
“antiviral compound prevents Ebola virus infection with limited to no morbidity in treated animals at any point of treatment following infection by this lethal virus”
CNO: Re-Posting at request from October 15, 2012
Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases
A new Ebola virus study resulting from a widespread scientific collaboration has shown promising preliminary results, preventing disease in infected nonhuman primates using monoclonal antibodies.
In this week’s online edition of the Proceedings of the National Academy of Sciences (PNAS), the research team describes a proof-of-concept for using a “cocktail” of monoclonal antibodies, or mAbs, to prevent lethal disease in rhesus macaques. When administered one hour after infection, all animals survived. Two-thirds of the animals were protected even when the treatment, known as MB-003, was administered 48 hours after infection.
Ebola virus, which causes hemorrhagic fever with human case fatality rates as high…
View original post 603 more words